US 2023/0058142 A1 · LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINE

Abstract

The present invention relates to a liquid pharmaceutical composition comprising cytisine, at least one inorganic pH-regulating agent selected from the group consisting of inorganic acids, inorganic buffers, and inorganic acid salts, and water, wherein the liquid pharmaceutical composition has a pH value between 3.0 and 7.5. The present invention furthermore relates to the liquid harmaceutical composition for use in the treatment of tobacco smoking addiction and other forms of nicotine addiction. Additionally, the invention relates to a liquid pharmaceutical composition comprising cytisine for oral use in the treatment of tobacco smoking addiction and other forms of nicotine addiction.

Claims19

Dependent claims

A liquid pharmaceutical composition comprising:

cytisine;
at least one inorganic pH-regulating agent selected from inorganic acids, inorganic buffers, or inorganic acid salts;
and
water;
wherein the liquid pharmaceutical composition has a pH value between 3.0 and 7.5.

2 more elements

Dependencies are inferred from the claim text.

Facts

Application

17/784,243Filed 6 Dec 2020

Priority

EP 19461613.210 Dec 2019

Published

23 Feb 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification15 codes

A61K 9/007
Galenical forms characterised by the site of application: pulmonary tract; Aromatherapy
A61K 31/198
The amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine,…:…
A24B 15/167
Of tobacco substitutes: in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
A61K 9/006
Mouth and digestive tract, i.e. intraoral and peroral administration: oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or…

Liquid pharmaceutical composition comprising cytisine

Life of this patent

Liquid pharmaceutical composition comprising cytisine

Life of this patent

Abstract

Claims19